The University of Chicago Header Logo

Connection

Scott Eggener to Thiohydantoins

This is a "connection" page, showing publications Scott Eggener has written about Thiohydantoins.
Connection Strength

0.060
  1. Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial. Clin Cancer Res. 2026 Feb 04; 32(3):479-488.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.